The DNASAS operates in much the same way as traditional access control/card reader systems, but that is where the similarity ends. The DNASAS uses a proprietary method to integrate stabilized botanical DNA within the actual microchip mounted on the surface of the access card. When the card is inserted into the reader, it will only operate or permit an operation if the DNA signature on the cards' microchip exactly matches a specific DNA model, in that specific reader.
The DNASAS reader technology is unique in the security industry and recently won the Best of Show and the Product Achievement Award for access control, at the National Summit on Security, sponsored by the Security Industry Association (SIA), whose membership includes market leaders like HID and ADT.
One of the most obvious security benefits of the DNASAS is that it shares very little in the way of core components with other security access systems on the market today. There are no other sources for key components other than Applied DNA Sciences, Inc. One of the main criticisms within the security industry has been that access control cards are now common and readily available to anyone to order, reorder or to replace a "lost" card. The integrity of the DNASAS product is also fortified by the integration of fingerprint recognition, providing absolute authentication between the cardholder, their fingerprint and a unique DNA code.
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. provides proprietary DNA-embedded security solutions, using plant (non-human) DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan whose technology is protected by 10 international patents. (http://www.biowell.com.tw/eng). Applied DNA Sciences, Inc., 9229 West Sunset Boulevard Los Angeles, CA 90069; Tel: 310.860.1362; Fax: 310.860.1303. www.ADNAS.com.
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the Company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks detailed in the Company's Registration Statement filed with the SEC.